| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1150 | 2021 |
| Intravascular Complications of Central Venous Catheterization by Insertion Site. SSG Parienti JJ, Mongardon N, Mégarbane B, Mira JP, Kalfon P, Gros A, Marqué ... N Engl J Med, 2015 | 848* | 2015 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 671 | 2021 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 562 | 2017 |
| Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study G Lebreton, M Schmidt, M Ponnaiah, T Folliguet, M Para, J Guihaire, ... The Lancet Respiratory Medicine 9 (8), 851-862, 2021 | 198 | 2021 |
| Prevention of early ventilator-associated pneumonia after cardiac arrest B François, A Cariou, R Clere-Jehl, PF Dequin, F Renon-Carron, T Daix, ... New England Journal of Medicine 381 (19), 1831-1842, 2019 | 138 | 2019 |
| Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges G Voiriot, M Oualha, A Pierre, C Salmon-Gandonnière, A Gaudet, Y Jouan, ... Annals of intensive care 12 (1), 58, 2022 | 123 | 2022 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 120 | 2023 |
| Energetic dysfunction in sepsis: a narrative review S Preau, D Vodovar, B Jung, S Lancel, L Zafrani, A Flatres, M Oualha, ... Annals of Intensive Care 11, 1-21, 2021 | 108 | 2021 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 101 | 2021 |
| Management of pharmaceutical and recreational drug poisoning B Mégarbane, M Oberlin, JC Alvarez, F Balen, S Beaune, R Bédry, ... Annals of intensive care 10, 1-30, 2020 | 88 | 2020 |
| Preclinical septic shock research: why we need an animal ICU A Guillon, S Preau, J Aboab, E Azabou, B Jung, S Silva, J Textoris, F Uhel, ... Annals of intensive care 9, 1-11, 2019 | 80 | 2019 |
| Simultaneous determination of eight β-lactam antibiotics, amoxicillin, cefazolin, cefepime, cefotaxime, ceftazidime, cloxacillin, oxacillin, and piperacillin, in human plasma … T Legrand, D Vodovar, N Tournier, N Khoudour, A Hulin Antimicrobial Agents and Chemotherapy 60 (8), 4734-4742, 2016 | 80 | 2016 |
| Drug fever: a descriptive cohort from the French pharmacovigilance database D Vodovar, C LeBeller, B Mégarbane, A Lillo-Le-Louet, T Hanslik Drug safety 35 (9), 759-767, 2012 | 74 | 2012 |
| The optic nerve sheath diameter as a useful tool for early prediction of outcome after cardiac arrest: a prospective pilot study J Chelly, N Deye, JP Guichard, D Vodovar, L Vong, S Jochmans, ... Resuscitation 103, 7-13, 2016 | 61 | 2016 |
| Pediatric eye injuries by hydroalcoholic gel in the context of the coronavirus disease 2019 pandemic GC Martin, G Le Roux, D Guindolet, E Boulanger, D Hasle, E Morin, ... JAMA ophthalmology 139 (3), 348-351, 2021 | 50 | 2021 |
| Enterobacteriaceae producing extended spectrum beta-lactamase: epidemiology, risk factors, and prevention D Vodovar, G Marcadé, L Raskine, I Malissin, B Mégarbane La Revue de Médecine Interne 34 (11), 687-693, 2012 | 50* | 2012 |
| Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome D Vodovar, S El Balkhi, E Curis, N Deye, B Mégarbane Clinical Toxicology 54 (8), 615-623, 2016 | 49 | 2016 |
| Dramatic increase of amoxicillin-induced crystal nephropathy found in a cohort study of French pharmacovigilance centers D Vodovar, L Thomas, N Mongardon, R Lepeule, B Lebrun-Vignes, ... Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01630-17, 2018 | 48 | 2018 |
| Poisoning during the COVID-19 outbreak and lockdown: retrospective analysis of exposures reported to French poison control centres G Le Roux, S Sinno-Tellier, E Puskarczyk, M Labadie, K von Fabeck, ... Clinical Toxicology 59 (9), 832-839, 2021 | 45 | 2021 |